Clinical Trials Logo

Clinical Trial Summary

This study was designed to demonstrate the non-inferiority of MEDICURTAIN® (investigational device) compared to commercially available GUARDIX-SG® (control device) in treatment of subject who underwent total thyroidectomy for prevention of adhesion formation at 6 weeks after the surgery.


Clinical Trial Description

This clinical trial is a randomized, multi center, subject and evaluator blinded, parallel, comparative and non-inferiority clinical trial study to assess the prevention of adhesion formation in the subjects treated either MEDICURTAIN® or GUARDIX-SG at 6 weeks after total thyroidectomy. The primary endpoint was defined as abnormal findings of esophageal motility evaluated by the independent third evaluator using marshmallow esophagography. The objective of this study was to demonstrate the non-inferiority of investigational device versus control device for adhesion formation at 6 weeks after the administration of investigational or control devices. Esophageal motility score and clinical symptoms assessed by the independent third evaluator using marshmallow esophagography at 6 weeks after administration of investigational device were secondary outcome. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05058027
Study type Interventional
Source Shin Poong Pharmaceutical Co. Ltd.
Contact
Status Completed
Phase N/A
Start date July 4, 2013
Completion date August 28, 2014

See also
  Status Clinical Trial Phase
Completed NCT04638855 - The Efficacy and Safety of Medicurtain® in Patients With Hysteroscopy (Pivotal Study) N/A
Completed NCT04688281 - Spine Surgery for Adhesions in Patients Evaluated for Efficacy and Safety of MedicurtainⓇ (Pivotal Study) N/A
Completed NCT05049434 - Efficacy and Safety for Medicurtain® in Prevention of Adhesion After Endoscopic Sinus Surgery (Pivotal Study) N/A
Completed NCT04672421 - The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study) N/A